Adaptive Biotechnologies (ADPT) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $20.82 -3.16%
EPS Growth %: +17.6%
Financial Fact:
Operating loss: -32.21M
Today's EPS Names:
EPAC, SAR, KRUS, More
EPS Growth %: +17.6%
Financial Fact:
Operating loss: -32.21M
Today's EPS Names:
EPAC, SAR, KRUS, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q3 EPS of ($0.27), $0.01 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $26.3 million versus the consensus estimate of $23.58 million.
Cash, cash equivalents and marketable securities was $851.5 million as of September 30, 2020.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
- Tradeweb Markets (TW) PT Lowered to $151 at Raymond James
- Kura Sushi (KRUS) Tops Q3 EPS by 3c; offers outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
